A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
Condition(s):NF1; Low-grade GliomaLast Updated:March 15, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):NF1; Low-grade GliomaLast Updated:March 15, 2024Recruiting
Condition(s):HIV-1 Infected Adults With Chronic HIV-1 InfectionLast Updated:March 13, 2018Completed
Condition(s):Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin CancersLast Updated:December 17, 2020Completed
Condition(s):Melanoma; Squamous Cell Carcinoma of the Head and Neck; Squamous Cell Carcinoma of the Skin; Sarcoma of the Skin; Basal Cell Cancer of the Skin; Breast CancerLast Updated:January 23, 2018Terminated
Condition(s):Brain TumorsLast Updated:June 12, 2023Completed
Condition(s):Healthy VolunteersLast Updated:August 13, 2012Completed
Condition(s):Glioblastoma Multiforme; Glioblastoma, Adult; Glioma of Brain; Glioblastoma Multiforme of BrainLast Updated:December 27, 2022Active, not recruiting
Condition(s):Metastatic Colon Cancer; Solid TumorLast Updated:February 8, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:March 16, 2022Recruiting
Condition(s):CNS Tumor, AdultLast Updated:April 20, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.